K-Ras(G12C) Inhibitor 6
CAS No. 2060530-16-5
K-Ras(G12C) Inhibitor 6( K-Ras(G12C) Inhibitor 6 | MDK30165 )
Catalog No. M17423 CAS No. 2060530-16-5
K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 77 | In Stock |
|
| 5MG | 77 | In Stock |
|
| 10MG | 139 | In Stock |
|
| 25MG | 287 | In Stock |
|
| 50MG | 392 | In Stock |
|
| 100MG | 548 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameK-Ras(G12C) Inhibitor 6
-
NoteResearch use only, not for human use.
-
Brief DescriptionK-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.
-
DescriptionMDK30165, also known as K-Ras(G12C) Inhibitor 6. It has no formal code name. For the convenience of communication, we name it as MDK30165. It has CAS#2060530-16-5, in which the last 5 digit is used for its code name. K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.
-
In Vitro——
-
In Vivo——
-
SynonymsK-Ras(G12C) Inhibitor 6 | MDK30165
-
PathwayOthers
-
TargetOther Targets
-
RecptorK-Ras
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2060530-16-5
-
Formula Weight405.33
-
Molecular FormulaC17H22Cl2N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc(OCC(=O)N2CCC(NC(=O)CCCS)CC2)c(Cl)c1
-
Chemical NameN-(1-(2-(2,4-dichlorophenoxy)acetyl)piperidin-4-yl)-4-mercaptobutanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Sibeprenlimab
Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody that inhibits APRIL and may be investigated for the prevention and treatment of kidney disease (IgAN).
-
Zolamide
Zolamide may be used to prevent altitude sickness and reduce the symptoms.
-
Terlipressin
Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
Cart
sales@molnova.com